Table 2.
Drug-route complexity classification validation
| Drug-Route Dyad | Complexity Score | Consultant Opinion | Validation |
|---|---|---|---|
| Fentanyl IV a | Unanimous a | ||
| Amiodarone IV a | Unanimous a | ||
| Morphine IV a | Unanimous a | ||
| Norepinephrine IV a | High | High | Unanimous a |
| Heparin IV | Unanimous | ||
| Lidocaine IV | Consensus | ||
| Labetalol IV | Consensus | ||
| Oxycodone PO | Consensus | ||
| Lorazepam IV | Consensus | ||
| Prednisone PO | Consensus | ||
| Tacrolimus PO | Moderate | Moderate | Consensus |
| Quetiapine PO | Consensus | ||
| Magnesium sulfate PO | Consensus | ||
| Senna PO a | Unanimous a | ||
| Aspirin PO a | Unanimous a | ||
| Atorvastatin PO a | Unanimous a | ||
| Pantoprazole IV | Unanimous | ||
| Multivitamins PO | Low | Low | Unanimous |
| Cefazolin IV a | Consensus a | ||
| Acetaminophen PO | Consensus | ||
| Gabapentin PO | Consensus | ||
| Lisinopril PO | Consensus | ||
| Amlodipine PO | Consensus | ||
| Piperacillin/tazobactam IV a | Low | Moderate | Consensus a |
| Dexamethasone IV a | Low | Moderate | Consensus a |
| Albumin IV | Low | Moderate | Consensus |
| Potassium chloride PO | Low | Moderate | Consensus |
| Ondansetron PO | Low | Moderate | Consensus |
| Furosemide IV | Low | Moderate | Consensus |
| Metoprolol IV | High | Moderate | Consensus |
a
BOLD = selected for study.